quinazolines has been researched along with sumatriptan in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akerman, S; Goadsby, PJ; Gupta, S; Saxena, PR; van den Brink, AM; van den Maagdenberg, AM | 1 |
| Unger, J | 1 |
| Rapoport, AM | 1 |
| Dallel, R; Descheemaeker, A; Luccarini, P | 1 |
| Kayama, Y; Kitagawa, S; Nakahara, J; Shibata, M; Takizawa, T; Tang, C; Unekawa, M | 1 |
2 review(s) available for quinazolines and sumatriptan
| Article | Year |
|---|---|
Migraine headaches: a historical prospective, a glimpse into the future, and migraine epidemiology.
Topics: Benzamides; Benzopyrans; Calcitonin Gene-Related Peptide; Drug Therapy, Combination; Ergotamine; Global Health; Humans; Incidence; Indans; Migraine Disorders; Piperazines; Prevalence; Prospective Studies; Quinazolines; Randomized Controlled Trials as Topic; Spiro Compounds; Sumatriptan; Treatment Outcome; United States; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
New acute treatments for headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Botulinum Toxins, Type A; Clinical Trials as Topic; Diclofenac; Dipeptides; Drug Administration Routes; Headache Disorders; Humans; Piperazines; Quinazolines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents | 2010 |
3 other study(ies) available for quinazolines and sumatriptan
| Article | Year |
|---|---|
Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine.
Topics: Animals; Arteries; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Dura Mater; Electric Stimulation; Male; Mice; Mice, Inbred C57BL; Microscopy, Video; Migraine Disorders; Piperazines; Quinazolines; Serotonin Receptor Agonists; Skull; Sumatriptan; Trigeminal Caudal Nucleus; Vasodilation | 2006 |
Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.
Topics: Animals; Central Nervous System Sensitization; Dipeptides; Disease Models, Animal; Hyperalgesia; Isosorbide Dinitrate; Male; Migraine Disorders; Nitric Oxide Donors; Piperazines; Quinazolines; Rats; Rats, Sprague-Dawley; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents | 2018 |
Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebral Cortex; Chronic Pain; Cortical Spreading Depression; Dipeptides; Electrodes; Face; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Migraine with Aura; Movement; Photophobia; Piperazines; Prevalence; Quinazolines; Receptors, Serotonin; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Temperature | 2020 |